TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 285 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q1 2022. The put-call ratio across all filers is 0.15 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $309 | -1.6% | 20 | 0.0% | 0.00% | – |
| Q2 2023 | $314 | -4.8% | 20 | 0.0% | 0.00% | – |
| Q1 2023 | $330 | +5.8% | 20 | 0.0% | 0.00% | – |
| Q4 2022 | $312 | – | 20 | 0.0% | 0.00% | – |
| Q3 2022 | $0 | – | 20 | 0.0% | 0.00% | – |
| Q2 2022 | $0 | -100.0% | 20 | -89.5% | 0.00% | – |
| Q1 2022 | $3,000 | 0.0% | 190 | 0.0% | 0.00% | – |
| Q4 2021 | $3,000 | -99.4% | 190 | -99.3% | 0.00% | -100.0% |
| Q2 2020 | $486,000 | +15.2% | 27,113 | -2.6% | 0.04% | 0.0% |
| Q1 2020 | $422,000 | +2.7% | 27,825 | +33.7% | 0.04% | +11.4% |
| Q4 2019 | $411,000 | +13.5% | 20,808 | -1.0% | 0.04% | +6.1% |
| Q3 2019 | $362,000 | +160.4% | 21,024 | +167.5% | 0.03% | +120.0% |
| Q2 2019 | $139,000 | -12.6% | 7,860 | +1.0% | 0.02% | -21.1% |
| Q1 2019 | $159,000 | – | 7,783 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blackcrane Capital, LLC | 30,201 | $3,149,000 | 19.29% |
| MANAGED ASSET PORTFOLIOS, LLC | 1,399,878 | $20,046,000 | 2.75% |
| Clean Yield Group | 251,220 | $3,597,000 | 1.27% |
| Mondrian Investment Partners LTD | 4,319,715 | $60,476,000 | 1.24% |
| Sippican Capital Advisors | 80,490 | $1,153,000 | 0.96% |
| TFG Asset Management GP Ltd | 1,275,656 | $18,268,000 | 0.83% |
| Lumbard & Kellner, LLC | 132,516 | $1,898,000 | 0.74% |
| BRANDES INVESTMENT PARTNERS, LP | 2,109,846 | $30,213,000 | 0.65% |
| CAUSEWAY CAPITAL MANAGEMENT LLC | 1,601,046 | $22,927,000 | 0.55% |
| Ridgewood Investments LLC | 33,378 | $478,000 | 0.31% |